EMCUREEmcure Pharmaceuticals Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals · CARE: AA (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.1 this quarter.
Momentum from moving averages, Supertrend and RSI.
2 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
2 found · risk minor
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹2820 Cr | ₹325 Cr | 16.95% | 11.53% | ₹17.16 | 13.5x |
| Q1 FY2027 | ₹2580 Cr | ₹292 Cr | 16.39% | 11.33% | ₹15.50 | 13.5x |
| Q4 FY2026 | ₹2470 Cr | ₹244 Cr | 15.11% | 9.87% | ₹12.84 | 8.4x |
| Q3 FY2026 | ₹2363 Cr | ₹231 Cr | 16.42% | 9.79% | ₹12.16 | 9.3x |
| Q2 FY2026 | ₹2270 Cr | ₹251 Cr | 16.34% | 11.07% | ₹12.85 | 11.5x |
| Q1 FY2026 | ₹2101 Cr | ₹215 Cr | 15.11% | 10.23% | ₹10.92 | 11.9x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.